Aarti Pharmalabs Limited — Others, 08-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Aarti Pharmalabs has announced a board meeting to review the certificate regarding the dematerialization of securities for the quarter ended March 31, 2025, confirming compliance with SEBI regulations. MUFG Intime India, the company's Registrar and Share Transfer Agent, verified that no requests for dematerialization were received during this period and that all security certificates were appropriately handled and listed.

This announcement reinforces operational efficiency and compliance, potentially enhancing investor confidence. The lack of dematerialization requests may highlight stable shareholder engagement, suggesting a neutral impact on investor sentiment at this time.